Delayed bio-stimulant approvals
Approvals for three bio-stimulant products are expected by end of Q4 FY26; any delay could impact Q1 FY27 sales, as peak season starts in July.
high · analyst_question
Dhanuka Agritech Limited — Q3 FY26
Dhanuka Agritech reported a weak Q3 FY26 with revenue of ₹409.92 crore (down 7.9% YoY), EBITDA of ₹58.6 crore (down 22.4% YoY), and PAT of ₹40 crore (down 27.3% YoY).
bearish
high
Financial stats pending filing verification
Risk Intelligence
Material risks this quarter
Concise cards keep the risk register scannable while preserving evidence-level context in the underlying quarter data.
Risks
El Niño impact on kharif season
Early El Niño predictions could affect monsoon rains and farmer incomes, potentially reducing demand for agrochemicals in the kharif season.
medium · analyst_questionSupply chain risks in Bayer product transition
Transition of Bayer products to Dhanuka's control involves regulatory and supply chain dependencies; any disruption could affect sales.
medium · management_commentaryInventory buildup from misfired sales plan
Inventory of imported molecules increased due to lower-than-expected sales, potentially leading to higher carrying costs or write-downs.
medium · data_observation